North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ 6,153.0 million by 2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 29 tables and 73 figures, this 143-page report “North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
Based on Omics Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single Cell Genomics (SCG)
• Single Cell Transcriptomics (SCT)
• Single Cell Proteomics (SCP)
• Single Cell Metabolomics (SCM)
By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Research
o Oncology
o Cell Therapy
o Immunology
o Neurology
o Cell Biology
o Other Types of Clinical Research
• Translation Research
• Synthetic Biology
By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Human Samples
o Cancer Tissues
o Stem Cells
o Immune Cells
o Brain Cells
o Other Human Samples
• Animal Samples
• Microbial Samples
By Workflow, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single-Cell Isolation and Dispensing
o Fluorescence-Activated Cell Sorting (FACS)
o Microfluidics
o Magnetic-Activated Cell Sorting (MACS)
o Random Seeding
o Manual Cell Picking
o Laser Capture Microdissection
o Other Technologies of Single-Cell Isolation and Dispensing
• Single-Cell Analysis
o Polymerase Chain Reaction
o Next-Generation Sequencing
o Mass Cytometry
o Mass Spectrometry
o Other Technologies of Single-Cell Analysis
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research and Academic Laboratories
• Biopharmaceutical and Biotech Companies
• Contract Research Organizations (CROs)
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of North America Market by Product Type 46
3.1 Market Overview by Product Type 46
3.2 Instruments 48
3.3 Consumables 49
3.4 Software 50
4 Segmentation of North America Market by Omics Type 51
4.1 Market Overview by Omics Type 51
4.2 Single Cell Genomics (SCG) 53
4.3 Single Cell Transcriptomics (SCT) 54
4.4 Single Cell Proteomics (SCP) 55
4.5 Single Cell Metabolomics (SCM) 56
5 Segmentation of North America Market by Application 57
5.1 Market Overview by Application 57
5.2 Clinical Research 59
5.2.1 Oncology 61
5.2.2 Cell Therapy 62
5.2.3 Immunology 63
5.2.4 Neurology 64
5.2.5 Cell Biology 65
5.2.6 Other Types of Clinical Research 66
5.3 Translation Research 67
5.4 Synthetic Biology 68
6 Segmentation of North America Market by Sample Type 69
6.1 Market Overview by Sample Type 69
6.2 Human Samples 71
6.2.1 Cancer Tissues 73
6.2.2 Stem Cells 74
6.2.3 Immune Cells 75
6.2.4 Brain Cells 76
6.2.5 Other Human Samples 77
6.3 Animal Samples 78
6.4 Microbial Samples 79
7 Segmentation of North America Market by Workflow 80
7.1 Market Overview by Workflow 80
7.2 Single-Cell Isolation and Dispensing 82
7.2.1 Fluorescence-Activated Cell Sorting (FACS) 84
7.2.2 Microfluidics 85
7.2.3 Magnetic-Activated Cell Sorting (MACS) 86
7.2.4 Random Seeding 87
7.2.5 Manual Cell Picking 88
7.2.6 Laser Capture Microdissection 89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 90
7.3 Single-Cell Analysis 91
7.3.1 Polymerase Chain Reaction 93
7.3.2 Next-Generation Sequencing 94
7.3.3 Mass Cytometry 95
7.3.4 Mass Spectrometry 96
7.3.5 Other Technologies of Single-Cell Analysis 97
8 Segmentation of North America Market by End User 98
8.1 Market Overview by End User 98
8.2 Research and Academic Laboratories 100
8.3 Biopharmaceutical and Biotech Companies 101
8.4 Contract Research Organizations (CROs) 102
8.5 Other End Users 103
9 North America Market 2021-2031 by Country 104
9.1 Overview of North America Market 104
9.2 U.S. 107
9.3 Canada 110
9.4 Mexico 112
10 Competitive Landscape 114
10.1 Overview of Key Vendors 114
10.2 New Product Launch, Partnership, Investment, and M&A 117
10.3 Company Profiles 118
10x Genomics, Inc. 118
1CellBio, Inc. 120
Becton, Dickinson and Company 121
Berkeley Lights, Inc. 122
BGI Genomics Co., Ltd. 123
Bio-Rad Laboratories, Inc. 124
Bio-Techne Corporation 125
BioTuring, Inc. 126
Danaher Corporation (Cytiva Life Sciences) 127
Dolomite Bio 128
Fluidigm Corporation 129
Fluxion Biosciences 130
Illimina, Inc 131
Mission Bio, Inc. 132
Namocell, Inc. 133
NanoString Technologies, Inc. 134
Parse Biosciences, Inc. 135
Proteona 136
Qiagen N.V. 137
RareCyte, Inc. 138
Scipio Biosciences SAS 139
Shilps Sciences 140
Takara Bio Inc. (Takara Holdings) 141
Thermo Fisher Scientific Inc. 142
RELATED REPORTS 143
List of Tables:
Table 1. Snapshot of North America Single Cell Multiomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Comparison of Rare Disease in Different Countries 32
Table 5. World Health Spending by Region, $ bn, 2013-2020 34
Table 6. Main Product Trends and Market Opportunities in North America Single Cell Multiomics Market 38
Table 7. North America Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 46
Table 8. North America Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 51
Table 9. North America Single Cell Multiomics Market by Application, 2021-2031, $ mn 57
Table 10. North America Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 60
Table 11. North America Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 69
Table 12. North America Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 72
Table 13. North America Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 80
Table 14. North America Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 83
Table 15. North America Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 92
Table 16. North America Single Cell Multiomics Market by End User, 2021-2031, $ mn 98
Table 17. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 105
Table 18. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 109
Table 19. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 109
Table 20. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 109
Table 21. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 111
Table 22. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 111
Table 23. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 111
Table 24. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 113
Table 25. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 113
Table 26. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 113
Table 27. 10x Genomics, Inc.: Company Snapshot 118
Table 28. 10x Genomics, Inc.: Business Segmentation 119
Table 29. 10x Genomics, Inc.: Product Portfolio 119
